KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $70.2 million.

  • Idexx Laboratories' Tax Provisions rose 619.51% to $70.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.2 million, marking a year-over-year increase of 850.52%. This contributed to the annual value of $222.0 million for FY2024, which is 269.74% up from last year.
  • Per Idexx Laboratories' latest filing, its Tax Provisions stood at $70.2 million for Q3 2025, which was up 619.51% from $68.4 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Tax Provisions peaked at $70.2 million during Q3 2025, and registered a low of $29.1 million during Q4 2021.
  • For the 5-year period, Idexx Laboratories' Tax Provisions averaged around $51.7 million, with its median value being $53.2 million (2022).
  • As far as peak fluctuations go, Idexx Laboratories' Tax Provisions surged by 107481.84% in 2021, and later plummeted by 2039.9% in 2022.
  • Over the past 5 years, Idexx Laboratories' Tax Provisions (Quarter) stood at $29.1 million in 2021, then soared by 40.86% to $41.0 million in 2022, then increased by 10.09% to $45.1 million in 2023, then dropped by 10.87% to $40.2 million in 2024, then skyrocketed by 74.37% to $70.2 million in 2025.
  • Its last three reported values are $70.2 million in Q3 2025, $68.4 million for Q2 2025, and $67.4 million during Q1 2025.